Selective nucleic acid amplification from nucleic acid pools

US9862994B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9862994-B2
Application numberUS-201314376241-A
CountryUS
Kind codeB2
Filing dateFeb 8, 2013
Priority dateFeb 9, 2012
Publication dateJan 9, 2018
Grant dateJan 9, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are nucleic acids and methods for selectively amplifying in parallel tens of thousands of high quality oligonucleotides without common sequences. The resultant oligonucleotides can be used for a variety of purposes and applications including but not limited to DNA nano structure synthesis.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising: (a) a single-stranded template nucleic acid comprising a target sequence, a 5′ end having a first sequence, and a 3′ end having a second sequence such that, when the 5′ end and the 3′ end are juxtaposed, the first sequence and the second sequence form a subpool-specific region, wherein the subpool-specific region comprises a subpool-specific sequence and an endonuclease site and is flanked on each end by a nicking site; and (b) a primer that is complementary to and hybridizes to the subpool-specific sequence, wherein the target sequence is about 15 to about 100 nucleotides in length. 2. The composition of claim 1 , wherein when the 5′ end and the 3′ end are juxtaposed, they are not covalently linked. 3. A composition comprising: (a) a single-stranded template nucleic acid comprising a target sequence, a 5′ end having a first sequence, and a 3′ end having a second sequence such that, when the 5′ end and the 3′ end are juxtaposed, the first sequence and the second sequence form a subpool-specific region, wherein the subpool-specific region comprises a subpool-specific sequence and an endonuclease site and is flanked on each end by a nicking site; and (b) a primer that is complementary to and hybridizes to the subpool-specific sequence, wherein the subpool-specific region comprises at least two subpool-specific sequences, each subpool-specific sequence comprising an endonuclease site. 4. The composition of claim 1 , wherein the subpool-specific sequence is about 8 to about 20 nucleotides in length. 5. The composition of claim 1 , wherein the endonuclease site is unique. 6. A composition comprising: (a) a single-stranded template nucleic acid comprising a target sequence, a 5′ end having a first sequence, and a 3′ end having a second sequence such that, when the 5′ end and the 3′ end are juxtaposed, the first sequence and the second sequence form a subpool-specific region, wherein the subpool-specific region comprises a subpool-specific sequence and an endonuclease site and is flanked on each end by a nicking site; and (b) a primer that is complementary to and hybridizes to the subpool-specific sequence, wherein the nicking sites are the same. 7. The composition of claim 1 , wherein the primer is hybridized to the subpool-specific sequence. 8. A composition comprising (a) a plurality of single-stranded nucleic acids, each comprising a target sequence, a 5′ end having a first sequence, and a 3′ end having a second sequence such that, when the 5′ end and the 3′ end are juxtaposed, the first sequence and the second sequence form a subpool-specific region, wherein the subpool-specific region comprises a subpool-specific sequence and an endonuclease site and is flanked on each end by a nicking site; and (b) a plurality of primers that are complementary to and hybridize to the subpool-specific sequences, wherein the plurality of single-stranded nucleic acids comprises at least two subpools of single-stranded nucleic acids, each subpool having a unique subpool-specific sequence. 9. The composition of claim 8 , wherein each subpool comprises 1 to 1000 different target sequences. 10. The composition of claim 9 , wherein the target sequences are single-stranded DNA strands. 11. A method comprising: combining in a reaction mixture (a) a plurality of single-stranded nucleic acids, wherein each single-stranded nucleic acid comprises a target sequence, a 5′ end having a first sequence, and a 3′ end having a second sequence such that, when the 5′ end and the 3′ end are juxtaposed, the first sequence and the second sequence form a subpool-specific region, wherein the subpool-specific region comprises a subpool-specific sequence and an endonuclease site and is flanked on each end by a nicking site, (b) ligase, and (c) a first primer that is complementary to and hybridizes to the subpool-specific sequence; amplifying single-stranded nucleic acids using the first primer via rolling circle amplification to produce a first plurality of concatemers; contacting the first plurality of concatemers with a second primer that is complementary to and hybridizes to a sequence complementary to the subpool-specific sequence and digesting the first plurality of concatemers with an endonuclease to produce a first plurality of monomers; contacting the first plurality of monomers with ligase in the presence of the second primer; amplifying the first plurality of monomers from the second primer via rolling circle amplification to produce a second plurality of concatemers. 12. The method of claim 11 further comprising: contacting the second plurality of concatemers with a third primer that is complementary to and hybridizes to the subpool-specific sequence and digesting the second plurality of concatemers with an endonuclease to produce a second plurality of monomers; contacting the second plurality of monomers with ligase in the presence of the third primer; and amplifying the second plurality of monomers from the third primer via rolling circle amplification to produce a third plurality of concatemers. 13. The method of claim 11 , wherein when the 5′ end and the 3′ end are juxtaposed, they are not covalently linked. 14. The method of claim 11 , wherein the subpool-specific sequence is about 8 to about 20 nucleotides in length. 15. The method of claim 11 , wherein the endonuclease site is unique. 16. The method of claim 11 , wherein the nicking sites are the same.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9862994B2 cover?
Provided herein are nucleic acids and methods for selectively amplifying in parallel tens of thousands of high quality oligonucleotides without common sequences. The resultant oligonucleotides can be used for a variety of purposes and applications including but not limited to DNA nano structure synthesis.
Who is the assignee on this patent?
Dana Farber Cancer Inst Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6844. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).